• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢子宫内膜样癌预后列线图的构建与验证及临床特征:一项基于监测、流行病学和最终结果(SEER)数据库的队列研究

Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.

作者信息

Ye Wanlu, Wang Qing, Lu Yanming

机构信息

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110003, Liaoning, China.

出版信息

J Cancer Res Clin Oncol. 2023 Nov;149(15):13607-13618. doi: 10.1007/s00432-023-05172-5. Epub 2023 Jul 29.

DOI:10.1007/s00432-023-05172-5
PMID:37515614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10590339/
Abstract

BACKGROUND

Ovarian endometrioid carcinoma (OEC) is the second most commonly occurring ovarian epithelial malignancy, but the associated prognostic factors remain obscure. This study aimed to analyze independent prognostic factors for patients with OEC and to develop and validate a nomogram to predict the overall survival (OS) of these patients.

METHODS

Clinical information of patients with OEC (2000-2019) was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox analyses were used to identify independent prognostic factors, and nomogram models were constructed using independent prognostic factors. Receiver operating characteristic (ROC) curve, calibration plots, and decision curve analysis (DCA) were used to verify the accuracy and validity of the nomogram. Kaplan-Meier curves were used to compare the differences in OS and cancer-specific survival (CSS) among subgroups.

RESULTS

A total of 4628 patients with OEC were included, being divided into training (n = 3238) and validation (n = 1390) sets (7:3 ratio). On multivariate Cox analysis, AJCC stage, age, tumor size, differentiation, chemotherapy, and lymph node resection were significant predictors of survival outcomes (P < 0.05). Resection of 1-3 lymph nodes in early-stage OEC patients did not significantly prolong OS (P > 0.05), but resection of ≥ 4 lymph nodes in early-stage improved OS and CSS (P < 0.05). The OS of early-stage patients was not related to whether or not they received chemotherapy (P > 0.05). Lymph node resection and chemotherapy significantly improved the prognosis of patients with advanced OEC (P < 0.05). The c-index of nomogram prediction model was 0.782. ROC with good discrimination, calibration plots with high consistency, and DCA with large net benefit rate result in large clinical value.

CONCLUSION

AJCC stage, differentiation, tumor size, age, chemotherapy, and lymph node dissection were prognostic factors of OEC. The constructed nomogram prediction model can effectively predict the prognosis of OEC patients and improve the accuracy of clinical decision-making.

摘要

背景

卵巢子宫内膜样癌(OEC)是第二常见的卵巢上皮性恶性肿瘤,但其相关的预后因素仍不明确。本研究旨在分析OEC患者的独立预后因素,并开发和验证一种列线图以预测这些患者的总生存期(OS)。

方法

从监测、流行病学和最终结果(SEER)数据库中获取2000 - 2019年OEC患者的临床信息。采用单因素和多因素Cox分析来识别独立预后因素,并使用独立预后因素构建列线图模型。采用受试者工作特征(ROC)曲线、校准图和决策曲线分析(DCA)来验证列线图的准确性和有效性。使用Kaplan - Meier曲线比较各亚组之间OS和癌症特异性生存期(CSS)的差异。

结果

共纳入4628例OEC患者,分为训练集(n = 3238)和验证集(n = 1390)(比例为7:3)。多因素Cox分析显示,美国癌症联合委员会(AJCC)分期、年龄、肿瘤大小、分化程度、化疗和淋巴结切除是生存结局的显著预测因素(P < 0.05)。早期OEC患者切除1 - 3个淋巴结并未显著延长OS(P > 0.05),但早期切除≥4个淋巴结可改善OS和CSS(P < 0.05)。早期患者的OS与是否接受化疗无关(P > 0.05)。淋巴结切除和化疗显著改善了晚期OEC患者的预后(P < 0.05)。列线图预测模型的c指数为0.782。具有良好区分度的ROC曲线、高度一致性的校准图以及具有较大净获益率的DCA结果具有较大的临床价值。

结论

AJCC分期、分化程度、肿瘤大小、年龄化疗和淋巴结清扫是OEC的预后因素。构建的列线图预测模型能够有效预测OEC患者的预后,提高临床决策的准确性。

相似文献

1
Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.卵巢子宫内膜样癌预后列线图的构建与验证及临床特征:一项基于监测、流行病学和最终结果(SEER)数据库的队列研究
J Cancer Res Clin Oncol. 2023 Nov;149(15):13607-13618. doi: 10.1007/s00432-023-05172-5. Epub 2023 Jul 29.
2
Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.预测手术治疗的Ⅲ/Ⅳ期胃腺癌放疗或化疗获益的列线图模型的开发与验证
Front Oncol. 2023 Aug 14;13:1223857. doi: 10.3389/fonc.2023.1223857. eCollection 2023.
3
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.
4
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.基于监测、流行病学和最终结果数据库及单中心数据的可切除非小细胞肺癌伴淋巴结转移(N1或N2)患者生存列线图模型
Transl Lung Cancer Res. 2024 Mar 29;13(3):573-586. doi: 10.21037/tlcr-24-119. Epub 2024 Mar 27.
5
Establishment of prognostic nomogram for high-grade parotid gland mucoepidermoid carcinoma based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库建立高级别腮腺黏液表皮样癌的预后列线图
Ear Nose Throat J. 2025 Feb;104(2):NP75-NP84. doi: 10.1177/01455613221089994. Epub 2022 Apr 13.
6
Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment.盆腔廓清术治疗上皮性卵巢癌患者的预后因素和癌症特异性生存预测列线图。
Int J Clin Pract. 2023 Aug 17;2023:9219067. doi: 10.1155/2023/9219067. eCollection 2023.
7
A postsurgical prognostic nomogram for patients with lymph node positive rectosigmoid junction adenocarcinoma.直肠乙状结肠交界处淋巴结阳性腺癌患者的术后预后列线图。
BMC Gastroenterol. 2023 May 18;23(1):159. doi: 10.1186/s12876-023-02810-7.
8
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.阴性淋巴结对数比值/T分期作为根治性膀胱切除术后膀胱癌患者新的预后因素的预测价值。
Front Oncol. 2022 Jul 19;12:895413. doi: 10.3389/fonc.2022.895413. eCollection 2022.
9
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.预测老年上皮性卵巢癌患者总生存和癌症特异性生存的列线图。
J Ovarian Res. 2023 Apr 14;16(1):75. doi: 10.1186/s13048-023-01144-y.
10
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER database.预测接受手术切除的大肝细胞癌患者癌症特异性生存的列线图的开发与验证:基于监测、流行病学和最终结果(SEER)数据库的真实世界分析
J Gastrointest Oncol. 2024 Aug 31;15(4):1657-1673. doi: 10.21037/jgo-24-285. Epub 2024 Aug 20.

引用本文的文献

1
The impact of lymph node dissection on stage I ovarian endometrioid carcinoma: A US-China Comparative Analysis.淋巴结清扫术对Ⅰ期卵巢子宫内膜样癌的影响:中美比较分析
iScience. 2025 Feb 10;28(3):111986. doi: 10.1016/j.isci.2025.111986. eCollection 2025 Mar 21.

本文引用的文献

1
The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.完整手术分期及辅助化疗对Ⅰ期1级和2级子宫内膜样卵巢癌生存的影响。
Int J Gynecol Cancer. 2022 Apr 4;32(4):525-531. doi: 10.1136/ijgc-2021-003112.
2
Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.与子宫内膜样卵巢癌患者预后相关的临床因素和生物标志物特征 - 强调肿瘤分级。
Gynecol Oncol. 2022 Jan;164(1):187-194. doi: 10.1016/j.ygyno.2021.10.078. Epub 2021 Oct 25.
3
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
真实世界多中心子宫内膜样卵巢癌队列的临床病理特征:法国国家 ESME-Unicancer 数据库分析。
Gynecol Oncol. 2021 Oct;163(1):64-71. doi: 10.1016/j.ygyno.2021.07.019. Epub 2021 Jul 19.
4
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study.卵巢子宫内膜样癌和透明细胞癌:一项 21 年回顾性研究。
J Ovarian Res. 2021 May 4;14(1):63. doi: 10.1186/s13048-021-00804-1.
5
Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.完全分期淋巴结切除术是否能改善 I 期子宫内膜样上皮性卵巢癌的生存结局?一项采用倾向评分加权分析的多机构回顾性研究。
Jpn J Clin Oncol. 2021 Mar 3;51(3):387-392. doi: 10.1093/jjco/hyaa206.
6
Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.在接受全面分期手术之后,早期浆液性和子宫内膜样卵巢癌不需要化疗。
J Ovarian Res. 2020 Aug 9;13(1):91. doi: 10.1186/s13048-020-00694-9.
7
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.子宫内膜癌分子风险分层对子宫内膜样卵巢癌同样具有预后价值。
Clin Cancer Res. 2020 Oct 15;26(20):5400-5410. doi: 10.1158/1078-0432.CCR-20-1268. Epub 2020 Jul 31.
8
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.子宫内膜样卵巢癌的分子异质性:使用子宫内膜癌替代分子分类对 166 例的分析。
Am J Surg Pathol. 2020 Jul;44(7):982-990. doi: 10.1097/PAS.0000000000001478.
9
Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.更年期激素替代疗法与卵巢癌风险:一项荟萃分析。
Front Endocrinol (Lausanne). 2019 Dec 3;10:801. doi: 10.3389/fendo.2019.00801. eCollection 2019.
10
The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.同时存在子宫内膜异位症对卵巢透明细胞或子宫内膜样癌患者预后的影响。
Int J Gynaecol Obstet. 2019 Aug;146(2):177-183. doi: 10.1002/ijgo.12861. Epub 2019 May 29.